Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026)

Novartis Ag's (NVS) quarterly Goodwill & Intangibles came in at $68.8 billion in Q2 2026, up 25.64% year-over-year from $54.8 billion in Q2 2025, and up 2.7% quarter-over-quarter from $67.0 billion in Q1 2026.

Analysis

Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $68.8 billion for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles rose 25.64% year-over-year to $68.8 billion; the TTM figure through Jun 2026 stood at $68.8 billion (up 25.64% YoY), while the FY2025 annual figure was $68.3 billion, up 13.42% from the prior year.
  • Goodwill & Intangibles came in at $68.8 billion for Q2 2026 at Novartis Ag, up from $67.0 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $68.8 billion in Q2 2026 to a low of $31.0 billion in Q1 2023.
  • Average Goodwill & Intangibles over 5 years is $55.4 billion, with a median of $56.2 billion recorded in 2023.
  • Year-over-year, Goodwill & Intangibles slipped 17.71% in 2023 and soared 58.97% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $60.9 billion in 2022, then decreased by 4.31% to $58.3 billion in 2023, then grew by 3.24% to $60.2 billion in 2024, then climbed by 13.42% to $68.3 billion in 2025, then rose by 0.82% to $68.8 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $68.8 billion in Q2 2026, $67.0 billion in Q1 2026, and $68.3 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.84 Bn
Mar 31, 2026 67.03 Bn
Dec 31, 2025 68.28 Bn
Sep 30, 2025 54.59 Bn
Jun 30, 2025 54.79 Bn
Mar 31, 2025 52.44 Bn
Dec 31, 2024 60.21 Bn
Sep 30, 2024 52.83 Bn
Jun 30, 2024 53.01 Bn
Mar 31, 2024 49.34 Bn
Dec 31, 2023 58.32 Bn
Sep 30, 2023 49.83 Bn
Jun 30, 2023 57.53 Bn
Mar 31, 2023 31.03 Bn
Dec 31, 2022 60.95 Bn
Sep 30, 2022 60.56 Bn
Jun 30, 2022 62.48 Bn
Mar 31, 2022 35.00 Bn
Dec 31, 2021 63.78 Bn
Sep 30, 2021 63.52 Bn